Literature DB >> 31697904

The Value and Caveats of Interpreting Small Case Series: Implications for Patient Care.

Richard K Parrish1, Ta Chen Chang2, Sarah L Duncan Powers3.   

Abstract

PURPOSE: To discuss the value and limitations of interpreting small case series for the purpose of understanding the pathophysiology of conditions affecting the visual system and how they may influence patient care decision making.
DESIGN: Selective review of English-language ophthalmic articles published in peer-reviewed journals since 1950.
METHODS: Author-initiated PubMed Central query of small case series in glaucoma, pediatric neuro-ophthalmology, and diabetic retinopathy.
RESULTS: A review of well-known ophthalmic case studies by Gass, Irvine, Brockhurst, and others shows that small samples can provide suggestions to the skilled clinician for adding steps to the examination process when uncovering rare or previously unknown associated complications, as is the case for this perspective's initiating studies by Groth and Brodsky. However, as shown by the now-retracted small case series in Lancet connecting measles-mumps-rubella vaccinations with autism, small case series do not replace the value of clinical trials, with rare exception, when considering impacts to widespread, common clinical practice.
CONCLUSION: Small case series may contribute to an improved understanding of pathophysiology of rare ophthalmic conditions, but alone are insufficient to provide evidence for changing clinical practice of common eye diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31697904      PMCID: PMC6954668          DOI: 10.1016/j.ajo.2019.10.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  TREATMENT OF DIABETIC RETINOPATHY BY LIGHT-COAGULATION: A PRELIMINARY STUDY.

Authors:  P C WETZIG; J T WORLTON
Journal:  Br J Ophthalmol       Date:  1963-09       Impact factor: 4.638

2.  Retraction of an interpretation.

Authors:  Simon H Murch; Andrew Anthony; David H Casson; Mohsin Malik; Mark Berelowitz; Amar P Dhillon; Michael A Thomson; Alan Valentine; Susan E Davies; John A Walker-Smith
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

3.  Retraction--Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors: 
Journal:  Lancet       Date:  2010-02-06       Impact factor: 79.321

4.  Prenatal or Perinatal Injury? Diagnosing the Cortically Blind Infant.

Authors:  Mai-Lan Ho; Sasha A Mansukhani; Michael C Brodsky
Journal:  Am J Ophthalmol       Date:  2019-11-05       Impact factor: 5.258

5.  Magnetic resonance imaging of periventricular leukomalacia and its clinical correlation in children.

Authors:  P Olsén; E Pääkkö; L Vainionpää; J Pyhtinen; M R Järvelin
Journal:  Ann Neurol       Date:  1997-06       Impact factor: 10.422

6.  A Randomized Controlled Trial Comparing Outcomes of Cataract Surgery in Nanophthalmos With and Without Prophylactic Sclerostomy.

Authors:  Sharmila Rajendrababu; Naresh Babu; Sapna Sinha; Vijayakumar Balakrishnan; Ashok Vardhan; George Varghese Puthuran; Pradeep Y Ramulu
Journal:  Am J Ophthalmol       Date:  2017-09-11       Impact factor: 5.258

7.  Nanophthalmos with uveal effusion: a new clinical entity.

Authors:  R J Brockhurst
Journal:  Trans Am Ophthalmol Soc       Date:  1974

8.  Nicotinic acid maculopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

9.  Cataract surgery in nanophthalmic eyes.

Authors:  R J Brockhurst
Journal:  Arch Ophthalmol       Date:  1990-07

10.  5-fluorouracil and glaucoma filtering surgery. II. A pilot study.

Authors:  D K Heuer; R K Parrish; M G Gressel; E Hodapp; P F Palmberg; D R Anderson
Journal:  Ophthalmology       Date:  1984-04       Impact factor: 12.079

View more
  1 in total

1.  Ophthalmologists Are More Than Eye Doctors-In Memoriam Li Wenliang.

Authors:  Richard K Parrish; Michael W Stewart; Sarah L Duncan Powers
Journal:  Am J Ophthalmol       Date:  2020-03-09       Impact factor: 5.258

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.